206 related articles for article (PubMed ID: 9417556)
1. [The current status of implantable automatic defibrillators].
Villacastín JP
Rev Esp Cardiol; 1997 Oct; 50(10):675-81. PubMed ID: 9417556
[TBL] [Abstract][Full Text] [Related]
2. Advances in the treatment of arrhythmias: implantable cardioverter-defibrillators.
Groh WJ; Foreman LD; Zipes DP
Am Fam Physician; 1998 Jan; 57(2):297-307, 310-2. PubMed ID: 9456993
[TBL] [Abstract][Full Text] [Related]
3. Pacemakers, defibrillators, and direct current cardioversion.
Sgarbossa EB; Black IW; Maloney JD
Curr Opin Cardiol; 1993 Jan; 8(1):27-38. PubMed ID: 10148086
[TBL] [Abstract][Full Text] [Related]
4. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.
Klein HU; Goldenberg I; Moss AJ
Eur Heart J; 2013 Aug; 34(29):2230-42. PubMed ID: 23729691
[TBL] [Abstract][Full Text] [Related]
5. Antitachycardia devices: realities and promises.
Klein LS; Miles WM; Zipes DP
J Am Coll Cardiol; 1991 Nov; 18(5):1349-62. PubMed ID: 1918713
[TBL] [Abstract][Full Text] [Related]
6. New generations of implantable pacemaker defibrillators for ventricular and atrial tachyarrhythmias.
Saksena S; Prakash A; Madan N; Giorgberidze I; Munsif AN; Mathew P; Kaushik R; Krol RB
Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():149-54. PubMed ID: 8734177
[TBL] [Abstract][Full Text] [Related]
7. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
[TBL] [Abstract][Full Text] [Related]
8. Advances in implantable cardioverter defibrillator therapy.
Rickard J; Wilkoff BL
Expert Rev Cardiovasc Ther; 2016; 14(3):291-9. PubMed ID: 26653411
[TBL] [Abstract][Full Text] [Related]
9. [The implantable cardioverter/defibrillator (ICD). Developments up to the present time and future perspectives].
Brachmann J; Hilbel T; Schöls W; Beyer T; Schweizer M; Sterns L; Karolyi L; Melichercik J; Freigang KD; Kübler W
Herz; 1994 Oct; 19(5):246-50. PubMed ID: 8001897
[TBL] [Abstract][Full Text] [Related]
10. Peri-procedural routines, implantation techniques, and procedure-related complications in patients undergoing implantation of subcutaneous or transvenous automatic cardioverter-defibrillators: results of the European Snapshot Survey on S-ICD Implantation (ESSS-SICDI).
Lenarczyk R; Boveda S; Haugaa KH; Potpara TS; Syska P; Jedrzejczyk-Patej E; Chauvin M; Sadoul N; Dagres N
Europace; 2018 Jul; 20(7):1218-1224. PubMed ID: 29762683
[TBL] [Abstract][Full Text] [Related]
11. Trends and Implications of DF-4 Implantable Cardioverter-Defibrillator Lead Adoption in the United States of America.
Li JZ; Bhonsale A; Estes NAM; Jain SK; Kancharla K; Mezu-Chukwu U; Saba S; Shalaby AA; Voigt AH; Wang NC
Circ Arrhythm Electrophysiol; 2019 Mar; 12(3):e007134. PubMed ID: 30841723
[No Abstract] [Full Text] [Related]
12. The implantable cardioverter defibrillator: modern implantation techniques and their impact on outcomes.
Luceri RM; Zilo P; Weiss DN
Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():129-33. PubMed ID: 8734174
[TBL] [Abstract][Full Text] [Related]
13. Complications of permanent cardiac pacing in patients with persistent left superior vena cava.
Polewczyk A; Kutarski A; Czekajska-Chehab E; Adamczyk P; Boczar K; Polewczyk M; Janion M
Cardiol J; 2014; 21(2):128-37. PubMed ID: 24526508
[TBL] [Abstract][Full Text] [Related]
14. Implantable defibrillator diagnostic storage capabilities: evolution, current status, and future utilization.
Sarter BH; Callans DJ; Gottlieb GD; Schwartzman DS; Marchlinski FE
Pacing Clin Electrophysiol; 1998 Jun; 21(6):1287-98. PubMed ID: 9633072
[TBL] [Abstract][Full Text] [Related]
15. Role of implantable cardioverter-defibrillators in patients with continuous flow ventricular assist devices.
Boilson BA; Friedman PA
Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):663-5. PubMed ID: 23962858
[No Abstract] [Full Text] [Related]
16. Role of Surface Electrocardiograms in Patients with Cardiac Implantable Electronic Devices.
Locati ET; Bagliani G; Testoni A; Lunati M; Padeletti L
Card Electrophysiol Clin; 2018 Jun; 10(2):233-255. PubMed ID: 29784482
[TBL] [Abstract][Full Text] [Related]
17. Implantable cardiac defibrillators.
Peters RW; Gold MR
Med Clin North Am; 2001 Mar; 85(2):343-67, xi. PubMed ID: 11233952
[TBL] [Abstract][Full Text] [Related]
18. Eligibility of Pacemaker Patients for Subcutaneous Implantable Cardioverter Defibrillators.
Ip JE; Wu MS; Kennel PJ; Thomas G; Liu CF; Cheung JW; Markowitz SM; Lerman BB
J Cardiovasc Electrophysiol; 2017 May; 28(5):544-548. PubMed ID: 28185354
[TBL] [Abstract][Full Text] [Related]
19. Advances in implantable cardioverter defibrillators.
Swygman C; Wang PJ; Link MS; Homoud MK; Estes NA
Curr Opin Cardiol; 2002 Jan; 17(1):24-8. PubMed ID: 11790930
[TBL] [Abstract][Full Text] [Related]
20. Should Single-Coil Implantable Cardioverter Defibrillator Leads Be Used in all Patients?
Almehmadi F; Manlucu J
Card Electrophysiol Clin; 2018 Mar; 10(1):59-66. PubMed ID: 29428142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
